2026-08-24 · Semis Sink, US-Canada Trade War Escalates

Chip stocks led today's selloff as the US-Canada trade war went live, even as broad market breadth stayed intact and today's confirmed reversal signals concentrated almost entirely in health care. AppLovin and Amgen capture the split: a contested falling-knife bounce against Wall Street's still-bullish view, and a fundamentally strong name stretched too far after a hot summer rally.The SignalStocks slipped to start the week as chip stocks led the way down, with Nvidia falling sharply into its earnings report later this week and the Nasdaq underperforming the broader tape by a wide margin. The Dow actually eked out a small gain, so this wasn't broad risk-off, it was money leaving the market's most crowded corner. Two policy stories drove the tape. The Treasury Department rolled out a new sanctions push targeting dozens of entities tied to Iran's oil, shipping and gold trade, a tailwind for energy. Bigger, the trade war with Canada went live: talks between Washington and Ottawa collapsed Friday, steep tariffs on tens of billions of dollars of Canadian goods took effect over the weekend, the administration is threatening to double auto tariffs from January, and Canada has matching retaliation queued for early September. The volatility index sits near its lowest level of the year, pricing in little of any of it.The NoiseStrip away the chip-driven wobble and the broad picture is still constructive: most of the market remains classified as accumulated, and stocks in a longer-term uptrend outnumber those in a downtrend by a healthy margin. What's unusual is how lopsided the shorter-term extension reads are. Confirmed reversal signals are running heavily bearish, and that skew sits almost entirely in health care, which supplies close to half of every bearish read today, alongside some technology-services and payments names stretched well above where our models expect them to sit after a summer of defensive-trade buying. On the other side, every single bullish setup the scan flagged is sitting inside a downtrend with money still flowing out, capitulation bounces rather than comfortable dip-buys. The rotation underneath is the part worth watching: distribution is clustering in health care while fresh accumulation shows up in industrials and materials, cyclical, old-economy sectors that would get hurt by the Canada tariff escalation the market hasn't fully priced.Multi-Signal ConfluenceAppLovin is the standout among today's short list of nine bullish setups, one of the rare ones where the weekly chart actually agrees with the short-term bullish signal. The company runs an AI-driven advertising platform that started in mobile gaming and is expanding into e-commerce and consumer apps; it just posted a strong quarter and gained more ad-spend share than any other network, but guidance came in light and the new consumer-ads business, generally available only since June, is ramping slower than hoped. The stock is roughly cut in half this year and still making fresh lows. Wall Street's fundamental view has barely budged, with several banks reiterating buy ratings and average price targets implying significant upside, but the price action itself is a classic falling-knife pattern, not a dip-buy, until a confirmed reversal or a flip in money flow shows up.Amgen is the flip side: a strong business that ran too far, too fast. Its early-August results were strong enough that several analysts raised price targets, and the stock has traded near record highs. Its biggest pipeline story is an obesity drug that showed up to 20% weight loss in mid-stage trials, positioned as a monthly injection rather than the weekly shots that dominate the category today, a real differentiator if it holds up in later trials. But the stock is stretched several standard deviations above where its trend model expects it to sit, with a confirmed bearish reversal signal and heavy money flow already rotating out, a name from today's health-care rotation story that argues for locking in gains and tightening stops rather than chasing it higher.Week AheadA big chunk of the market's risk sits inside one 72-hour window this week. Wednesday morning brings the July core inflation report, the Fed's preferred gauge; Wednesday afternoon, after the close, Nvidia reports earnings, a name that sits at the center of major index funds regardless of who owns the stock directly. Friday, the new Fed chair delivers his first keynote as chair at Jackson Hole; the official topic is payments policy, but markets will be listening for one thing, whether he leans dovish or hawkish on rates. Layer on the escalating Canada trade fight and the new Iran sanctions, and it's a week to stay nimble.Data as of the August 24, 2026 close.Educational research only, not investment advice. Stay sharp.